FeesSafety
Pluang+

Cardano Foundation joins Swiss CMTA, advancing tokenized shares with CIP-0113 standard recognition.

Protocol Fundamentals
29 Oct 2026, 13:50 WIB
Crypto news
View Source
Bullish
Cardano Foundation joins Swiss CMTA, advancing tokenized shares with CIP-0113 standard recognition.

Cardano Foundation has become a member of Switzerland's Capital Markets and Technology Association (CMTA), which recognized Cardano's CIP-0113 token standard as technically equivalent to CMTA's CMTAT framework for tokenized shares. This recognition allows companies to use Cardano's programmable token standard for issuing equity securities under Swiss law, though individual issuers must still meet legal and certification requirements. The Foundation has already applied CIP-0113 to tokenize shares in Veridian, a spinout company. Moving forward, Cardano and CMTA will collaborate to develop standards for tokenized capital markets, expanding blockchain use in regulated securities.

Cardano Foundation's new role in Swiss tokenized shares regulation provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 29, 2026 17:53 WIB: out of 50 major cryptocurrencies, 7 rose and 42 fell today. Notable movers include ONE (Harmony) at Rp23 with a 1-day change of -4.75% and Pluang order activity of 71% Sell / 29% Buy, AXS (Axie Infinity) at Rp16,838 with -4.31% change and 99% Sell / 1% Buy activity, and KSM (Kusama) at Rp67,269 with -3.94% change and 87% Sell / 13% Buy activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App